Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial

Overview of attention for article published in Lancet Infectious Diseases, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

blogs: 3 blogs
twitter: 3885 X users

reddit: 2 Redditors

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 28 Mendeley

Summary Blogs X Reddit Dimensions citations

So far, Altmetric has seen 2 Reddit threads by 2 users.

Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial

User hexagonincircuit1594, in the COVID-19 subreddit, 28 Jun 2023

Very promising data from phase 3 study of the mucosal vaccine from China

User faloodehx, in the Not a lifestyle competition, but a shared vision subreddit, 28 Jun 2023

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.